NEAT1 and Alzheimer disease: The levels of NEAT1 are increased and the levels of miR-27a-3p are decreased and both are negatively correlated with AD patients that is related to the Aβ degree of sedimentation, which participates in the disease progression of AD and may become a therapeutic target of AD.